| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRUKER CORP | Chief Accounting Officer | Common Stock | 3,472 | $164,555 | $47.40 | 10 Mar 2025 | Direct |
| PIERIS PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (right to buy) | 249,080 | 24 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BRKR | BRUKER CORP | 10 Mar 2025 | 1 | +$23,698 | 4 | Chief Accounting Officer | 11 Mar 2025, 16:11 |
| BRKR | BRUKER CORP | 15 Feb 2025 | 1 | $0 | 4 | Chief Accounting Officer | 19 Feb 2025, 16:39 |
| BRKR | BRUKER CORP | 13 Jan 2025 | 0 | $0 | 3 | Chief Accounting Officer | 16 Jan 2025, 17:17 |
| PIRS | PIERIS PHARMACEUTICALS, INC. | 24 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 28 Feb 2023, 16:39 |
| PIRS | PIERIS PHARMACEUTICALS, INC. | 22 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 24 Feb 2022, 15:46 |